Search - tctmd.com

Displaying 581 - 598 of 598

Sort: Relevancy | Date

CME

Aortic Stenosis, TAVR, ViV-TAVR: Peri-procedural Hemodynamics

Video

Optimal Hemodynamics- TAVI or SAVR- - L. Sondergaard

January 9, 2020

Video

Failed Aortic Valve Bioprostheses- Valve-in-Valve or Redo-SAVR- - D. Dvir

January 9, 2020

Partner Content

The Foundations of TAVR - Medtronic

October 29, 2019

Video

» Live Case

TVT 2019: Live Case #15: NYP/Columbia — TAVR Sapien Ultra

June 25, 2019

Video

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

June 14, 2019

Video

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

June 14, 2019

Video

TVT 2019: Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

June 13, 2019

Video

TVT 2019: Highlights From the Evolut Low-Risk Trial

June 13, 2019

CME

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

CME

New Clinical Data on TAVR use and Intermediate Risk Patients

CME

Defining Cost-Effectiveness and Quality of Life for TAVR

Video

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

June 26, 2018

Video

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

June 26, 2018

CME

Emerging Indications for TAVR

CME

TAVR: Economics & Efficiencies

CME

Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

CME

Advertisement

Aortic Stenosis, TAVR, ViV-TAVR: Peri-procedural Hemodynamics

Optimal Hemodynamics- TAVI or SAVR- - L. Sondergaard

Failed Aortic Valve Bioprostheses- Valve-in-Valve or Redo-SAVR- - D. Dvir

The Foundations of TAVR - Medtronic

TVT 2019: Live Case #15: NYP/Columbia — TAVR Sapien Ultra

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

TVT 2019: Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

TVT 2019: Highlights From the Evolut Low-Risk Trial

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

New Clinical Data on TAVR use and Intermediate Risk Patients

Defining Cost-Effectiveness and Quality of Life for TAVR

SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Emerging Indications for TAVR

TAVR: Economics & Efficiencies

Evolving Thresholds for TAVR - Moving Down the Risk Spectrum

Expanded TAVR Indications: Post TCT 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content